CN102614264A - Medicine for treating eyelid spasm - Google Patents

Medicine for treating eyelid spasm Download PDF

Info

Publication number
CN102614264A
CN102614264A CN2012101312478A CN201210131247A CN102614264A CN 102614264 A CN102614264 A CN 102614264A CN 2012101312478 A CN2012101312478 A CN 2012101312478A CN 201210131247 A CN201210131247 A CN 201210131247A CN 102614264 A CN102614264 A CN 102614264A
Authority
CN
China
Prior art keywords
medicament
medicine
promoting
root
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012101312478A
Other languages
Chinese (zh)
Inventor
马守云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2012101312478A priority Critical patent/CN102614264A/en
Publication of CN102614264A publication Critical patent/CN102614264A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to medicament, in particular to a medicine prepared from Chinese medicinal materials serving as raw materials and used for treating eyelid spasm. The medicament consists of centipede, Chinese angelica, szechuan lovage rhizome, white paeony root, red paeony root, leech, scorpio, typhonium giganteum, stiff silkworm, Chinese ephedra, dahurian angelica root, astragalus, divaricate saposhnikovia root and earthworm. A method for preparing the medicament comprises the following the steps of: uniformly mixing the medicinal materials according to parts by weight; smashing into medicinal powder of 100-120 meshes; and sterilizing, disinfecting, and preparing a water pill product by using a bonding agent according the conventional method. The medicament provided by the invention has the effects of promoting blood circulation, promoting qi circulation, removing obstruction in the collateral, nourishing blood and liver, relieving pain, expelling wind-dampness, activating blood, expelling pus, promoting tissue regeneration and relieving pain, and has the advantages of treatment of both principal and secondary aspects of eyelid spasm, definite curative effect, no toxic or side effect or anaphylactic reaction, high curative rate, no side effects of other western medicinal preparations on liver and kidney injuries and the like, no medicament resistance of business antibiotics and the like, and easiness for a patient to accept.

Description

A kind of medicine of treating blepharospasm
Technical field
The present invention relates to a kind of medicine, being specially a kind of is the medicine of the treatment blepharospasm of feedstock production with the Chinese crude drug.
Background technology
Blepharospasm means the spontaneous spastic contraction of all orbicular muscle of eye, socket of the eye and socket of the eye.Being mainly in middle-aged and elderly people, is one of common disease of ophthalmology, brings great misery through the audit health for the patient, also extremely influences attractive in appearance.It does not have the clonicity of lower face muscle to twitch.It is changeable to continue the spasm time, spasm show as the continuous repetition that non-will property is closed one's eyes strongly.Many blepharospasm patients are obtaining having stood the misery of long duration before clear and definite diagnosis and the treatment, and have often delayed timely treatment because of mistaken diagnosis.
China develops A type meat poison crystalline toxin in the nineties, and is applied to clinical.Through zoopery and clinical and experimental study, quality, purity and effect of drugs all reach external similar drug level.Botulinum toxin mainly acts on the cholinoceptor of teleneuron, and antagonism Ca combines with cholinoceptor.Suppress the release of acetylcholine, thereby muscle can't be shunk from teleneuron.
The advantage of creotoxin treatment: ⑴ instant effect, total treatment effective percentage are high.⑵ relatively have simple and easy to do, little, the few side effects of damage with operation.⑶ expense is low, is prone to be accepted by patient, and patient is ready repetitive therapy.
The shortcoming of creotoxin treatment: the ⑴ relapse rate is high.⑵ need treatment periodically repeatedly.⑶ be prone to cause local serial side reaction: the ptosis, diplopia, xerophthalmia and exposure keratitis etc.⑷ the treatment of creotoxin can only be a kind of expectant treatment of temporary relief of symptoms, but not the essence treatment.
Botulinum toxin causes owing to toxin acts on cranial nerve nuclei and peripheral nervous neuromuscular junction place and vegetative nerve tip after intestinal absorption people's toxic action.Be generally several hours to a couple of days incubation period after the botulism, and the symptom of cranial nerve palsy is arranged earlier, like headache, dizziness.Eye symptom appears then: because the platycoria that the inner and external flesh of eyes paralysis causes is regulated infringement, blepharoptosis, diplopia, blurred vision etc.Pharyngeal neural paralysis can have dysphagia, chew insensitive, hoarseness, aphasis.Cause dyspnea at a distance from myoparalysis, the difficulty that comes back, ataxia; Limb paralysis etc.Patient dies from dyspnea and heart failure more.
Summary of the invention
To the deficiency of prior art, the purpose of this invention is to provide a kind of medicine of treating blepharospasm, this medicine is short medicine time, makes things convenient for medication, and cure rate is high, and relapse rate is low.
Medicine of the present invention is that raw material makes by following parts by weight of traditional Chinese medicines:
Scolopendra 3-6 Radix Angelicae Sinensis 9-12
Rhizoma Chuanxiong 12-15 Radix Paeoniae Albas 10-12
Radix Paeoniae Rubra 12-15 Hirudos 10-12
Scorpio 6-9 Herba Typhonii gigantei 9-13
Bombyx Batryticatus 6-9 Herba Ephedraes 3-5
The Radix Angelicae Dahuricae 6-9 Radixs Astragali 15-20
Windproof 6-9 Pheretimas 8-12.
The medicine of above-mentioned each component can be processed said peroral dosage form on any pharmaceuticss such as tablet, pill, powder, capsule, and the preferred dosage form of the present invention is a water pill.
The concrete method for preparing of medicine water pill of the present invention agent is: said medicine by said parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and sterilization uses binding agent to make the water pill product by conventional method.
Blepharospasm is that senile brain stem degeneration causes or is due to the neural discomfort of face.The traditional Chinese medical science is claimed " eyelid twitch ", and the traditional Chinese medical science is thought liver, temper blood discord, gives birth in the incoordination between nutrient QI and defensive QI wind-fire, and muscle is become homeless and supported and cause a face muscles tramp.
In the prescription of the present invention, that Scolopendra relieves internal heat is anticancer, relieving spasm by calming endogenous wind, move back inflammation and control skin ulcer; Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation; The Rhizoma Chuanxiong blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; The Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant; Radix Paeoniae Rubra clots absorbing, pain relieving, removing heat from blood, detumescence; Diseases such as Hirudo menstruation apolipsis, lump in the abdomen stomachache, blood-retention, traumatic blood stasis are had a pain, carbuncle erysipelas; Scorpio endogenous wind stopping spasmolytic, dispersing pathogen accumulation, removing obstruction in the collateral to relieve pain; The Herba Typhonii gigantei drying dampness to eliminate phlegm is expellingged wind and relieving convulsion, the detoxicating and resolving stagnation of pathogens pain relieving; The Bombyx Batryticatus expelling wind for relieving convulsion, dissipating phlegm and resolving masses; Herba Ephedrae diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema; Radix Angelicae Dahuricae wind-damp dispelling, the evacuation of pus of invigorating blood circulation, granulation promoting pain relieving; Radix Astragali benefiting QI for strengthening the superficies, arresting sweating take off, hold in the palm the effect of skin ulcer granulation promoting, inducing diuresis to remove edema admittedly; Windproof expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion is jerked surely; The Pheretima heat clearing away, spasmolytic, diuresis, detoxifcation.More than all medicines share blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, nourishing blood to suppress the hyperactive liver, slow in pain relieving, wind-damp dispelling, the evacuation of pus of invigorating blood circulation, the merit of granulation promoting pain relieving.The treatment treating both the principal and secondary aspects of a disease that is used for blepharospasm, determined curative effect has no side effect and anaphylaxis, and cure rate is high, does not have other Western medicine prepns to side reactions such as liver, renal damages, and the drug resistance of professional antibiotic etc. is easy to the patient and accepts.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 150 routine blepharospasm patients that the curative effect of medicine of the present invention is carried out clinical observation.
150 routine cases are divided into two groups at random, and 76 examples are organized in treatment, matched group 74 examples.
The treatment group: use medicine of the present invention, each 20, every day three times, warm water takes.Matched group: Carbamazepine Tablets (ShangHai Fudan Fuhua Pharmaceutical Co., Ltd's production), the each 100~200mg of predose, increases dosage until optimum curative effect gradually at every day 1~2 time.
Press blepharospasm strength grading assessments such as Cohen:
0 grade: no spasm;
The I level: outside stimulus causes to twinkle and increases:
The II level: slight, the eyelid facial muscle slightly trembles, no dysfunction;
The III level: moderate, spasm is obvious, and slight dysfunction is arranged;
The IV level: severe, serious spasm and dysfunction influence work and life.
The criterion of therapeutical effect evaluation:
1. alleviate fully: III~IV level is reduced to 0 grade;
2. obviously alleviate: the spasm classification descends >=2 grades;
3. part is alleviated: spasm classification decline I level;
4. invalid: the spasm classification does not have reduction.
Two groups of case treatment back curative effect comparative results are seen table 1.
Table 1 liang group case treatment back curative effect relatively
Group The example number Alleviate n (%) fully Obviously alleviate n (%) Part is alleviated n (%) Invalid n (%) Total effective rate n (%)
Matched group 74 36(48.6) 18(24.3) 5(6.8) 15(20.3) 59(79.7)
The treatment group 76 58(76.3) 13(17.1) 3(3.9) 2(3.4) 74(97.4)
Clinical experiment is the result prove, drug effect of the present invention obviously is superior to matched group, do not see any untoward reaction.
The specific embodiment
Embodiment 1
Get Scolopendra 6kg, Radix Angelicae Sinensis 12 kg, Rhizoma Chuanxiong 15 kg, the Radix Paeoniae Alba 12 kg, Radix Paeoniae Rubra 15 kg; Hirudo 12 kg, Scorpio 9 kg, Herba Typhonii gigantei 13 kg, Bombyx Batryticatus 9 kg; Herba Ephedrae 5 kg, the Radix Angelicae Dahuricae 9 kg, the Radix Astragali 20 kg, windproof 9 kg; Pheretima 12 kg by said parts by weight mix homogeneously, are ground into 100~120 purpose medicated powder with said medicine, and sterilization uses binding agent to make the water pill product by conventional method.
Embodiment 2
Get Scolopendra 3kg, Radix Angelicae Sinensis 9kg, Rhizoma Chuanxiong 12 kg, Radix Paeoniae Alba 10kg, Radix Paeoniae Rubra 12kg; Hirudo 10kg, Scorpio 6kg, Herba Typhonii gigantei 9kg, Bombyx Batryticatus 6kg; Herba Ephedrae 3kg, Radix Angelicae Dahuricae 6kg, Radix Astragali 15kg, windproof 6kg; Pheretima 8kg by said parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder with said medicine, and sterilization uses binding agent to make the water pill product by conventional method.

Claims (1)

1. medicine of treating blepharospasm is that raw material makes by following parts by weight of traditional Chinese medicines:
Scolopendra 3-6 Radix Angelicae Sinensis 9-12
Rhizoma Chuanxiong 12-15 Radix Paeoniae Albas 10-12
Radix Paeoniae Rubra 12-15 Hirudos 10-12
Scorpio 6-9 Herba Typhonii gigantei 9-13
Bombyx Batryticatus 6-9 Herba Ephedraes 3-5
The Radix Angelicae Dahuricae 6-9 Radixs Astragali 15-20
Windproof 6-9 Pheretimas 8-12.
CN2012101312478A 2012-05-02 2012-05-02 Medicine for treating eyelid spasm Pending CN102614264A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012101312478A CN102614264A (en) 2012-05-02 2012-05-02 Medicine for treating eyelid spasm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012101312478A CN102614264A (en) 2012-05-02 2012-05-02 Medicine for treating eyelid spasm

Publications (1)

Publication Number Publication Date
CN102614264A true CN102614264A (en) 2012-08-01

Family

ID=46554712

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012101312478A Pending CN102614264A (en) 2012-05-02 2012-05-02 Medicine for treating eyelid spasm

Country Status (1)

Country Link
CN (1) CN102614264A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104383227A (en) * 2014-12-19 2015-03-04 王金奎 Qi-reinforcing and blood-nourishing traditional Chinese medicine for treating eyelids quiver, and preparation method thereof
CN104524445A (en) * 2014-12-19 2015-04-22 王金奎 Wind-expelling and convulsion-relieving traditional Chinese medicine for treating twitching of eyelid and preparation method thereof
CN105687876A (en) * 2016-03-28 2016-06-22 杜凯 Traditional Chinese medicine granules for treating children blepharospasm
CN106860756A (en) * 2017-03-29 2017-06-20 卢仁华 The medicine of blepharospasm

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192296A (en) * 1992-10-28 1994-07-12 Chiba Pref Gov Production of crystal a type botulinus toxin as medicine for therapy
CN1966004A (en) * 2006-11-21 2007-05-23 李文杰 Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae
CN101167927A (en) * 2007-10-25 2008-04-30 寇连翠 Traditional Chinese medicine formula for treating eye and face spasm
CN101987148A (en) * 2009-07-31 2011-03-23 天津市公博科技开发有限公司 Chinese herbal medicine prescription for treating facial neuritis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192296A (en) * 1992-10-28 1994-07-12 Chiba Pref Gov Production of crystal a type botulinus toxin as medicine for therapy
CN1966004A (en) * 2006-11-21 2007-05-23 李文杰 Medicament for treating cerebrovascular and cardiovascular disease and apoplexy sequelae
CN101167927A (en) * 2007-10-25 2008-04-30 寇连翠 Traditional Chinese medicine formula for treating eye and face spasm
CN101987148A (en) * 2009-07-31 2011-03-23 天津市公博科技开发有限公司 Chinese herbal medicine prescription for treating facial neuritis and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张镜人: "《中医治疗疑难杂病秘药下》", 31 January 1994, 文汇出版社 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104383227A (en) * 2014-12-19 2015-03-04 王金奎 Qi-reinforcing and blood-nourishing traditional Chinese medicine for treating eyelids quiver, and preparation method thereof
CN104524445A (en) * 2014-12-19 2015-04-22 王金奎 Wind-expelling and convulsion-relieving traditional Chinese medicine for treating twitching of eyelid and preparation method thereof
CN105687876A (en) * 2016-03-28 2016-06-22 杜凯 Traditional Chinese medicine granules for treating children blepharospasm
CN106860756A (en) * 2017-03-29 2017-06-20 卢仁华 The medicine of blepharospasm

Similar Documents

Publication Publication Date Title
CN102920922B (en) Bone pain pill
CN102114088B (en) Chinese medicine preparation for treating bone fracture
CN101224278A (en) Medicine compounds for treating primary trigeminal neuralgia and preparing method thereof
CN101972413B (en) Traditional Chinese medicine for treating facial paralysis
CN101524450B (en) Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof
CN102614264A (en) Medicine for treating eyelid spasm
CN102166277A (en) Waist healing pill
CN1970045B (en) Externally applied Chinese medicine for treating cervical and lumbar spondylosis
CN102727856B (en) Volatile oil for treating arthralgia and injuries of tendons and preparation method of volatile oil
CN102247501A (en) Medicine for treating soft tissue injury
CN101327305A (en) Chinese medicine for treating appendicitis and preparation method thereof
CN103566278A (en) Pellet used for treating bone fracture
CN1274352C (en) Plaster for treating hyperosteogeny, protrusion of interverterbral disc, arthritis and periarthritis of shoulder joint and its prepn.
CN104013827A (en) Traditional Chinese medicine preparation for treating hemiparalysis
CN1186067C (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN101239140A (en) Chinese medicine for treating psoriasis
CN103585294A (en) Plaster for treating osteoproliferation and preparation method of plaster
CN102526544B (en) Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation
CN102018761B (en) Drug for treating vagina pruritus and preparation method thereof
CN102824460A (en) Medicine for treating urticaria
CN102670740A (en) Drug composition for treating soft tissue injuries and preparation process thereof
CN102631435A (en) Medicament for treating rheumatoid arthritis
CN107281444B (en) Analgesic pharmaceutical composition and preparation method and application thereof
CN101628044A (en) Medicine for treating esophagus cancer and preparation method thereof
CN104352569A (en) Trogopterus dung-containing traditional Chinese medicine composition for treating sprain

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120801